Search

Your search keyword '"Cassiman, David"' showing total 878 results

Search Constraints

Start Over You searched for: Author "Cassiman, David" Remove constraint Author: "Cassiman, David"
878 results on '"Cassiman, David"'

Search Results

52. EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms

56. Response by Kusters et al to Letter Regarding Article, “Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)”

58. Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network.

62. Uncovering monocyte transcription, functional and metabolic signatures in recovery and non-recovery ACLF patients

63. Clinical utility of non-ceruloplasmin copper determined by copper speciation for monitoring Wilson disease therapy: comparative data analysis with 24-hour urinary copper excretion from the CHELATE trial

64. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway

68. A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge

69. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria:A comparison between two genetic disorders affecting the same metabolic pathway

70. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway

73. Management dilemmas in pediatric nephrology: Cystinosis

77. Overlapping and divergent hepatic and lipoprotein phenotypes in untreated adults with acid sphingomyelinase deficiency versus untreated adults with Gaucher disease from two pivotal clinical trials

82. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

84. Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications

85. Genotype-Phenotype Correlations in PMM2-CDG

90. Hepatobiliary malignancies in Wilson disease

91. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis

94. Misdiagnosis as asphyxiating thoracic dystrophy and CMV-associated haemophagocytic lymphohistiocytosis in Shwachman-Diamond syndrome

95. Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease

96. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

Catalog

Books, media, physical & digital resources